Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins"
Count: 549
Selected: 0
NCT03576274Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer Survivors
NCT04499950Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study
NCT05058014Skeletal Metastasis Registry
NCT03861676Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
NCT03619655Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy
NCT03250273A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma
NCT04248569DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma
NCT00389610Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer
NCT03971734Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas
NCT02989636Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma
NCT03607890Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor
NCT06059118Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
NCT03965494AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery
NCT03914742BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
NCT02659800Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas
NCT02658981Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)
NCT02575794Terameprocol in Treating Patients With Recurrent High Grade Glioma
NCT03638141CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stage of HCC (Hepatocellular Carcinoma) Using Durvalumab and Tremelimumab
NCT05506956Post-transplant Flotetuzumab for AML
NCT06138067Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
NCT05013216Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer
NCT05083754Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
NCT00788164Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
NCT05977907Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN).
NCT03961971Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
NCT02845323Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder
NCT06027086DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)
NCT03006302Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer
NCT06122480Observation of Perioperative FOLFIRINOX for Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma
NCT05014776Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer
NCT04116073INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer
NCT03792516Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)
NCT02743910Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer
NCT05995821Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
NCT04713046Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers
NCT04232085Reduced Intensity BMT for Immune Dysregulatory and Bone Marrow Failure Syndromes Using Post-Transplant Cyclophosphamide
NCT02259621Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC
NCT05917301Pre-operative Hypofractionated Proton Therapy
NCT05716009Tagraxofusp-erzs, an IL-3 Diphtheria Fusion Protein, in Combination With Gemtuzumab Ozogamicin in Patients With Relapsed/Refractory AML
NCT05501548Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer
NCT04363164Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
NCT01088789A Trial of Boost Vaccinations of Pancreatic Tumor Cell Vaccine
NCT02451982Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas
NCT03190265Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer
NCT04117087Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected MMR-p Colorectal and Pancreatic Cancer
NCT05656235Renal Retention in High Grade Upper Tract Urothelial Cancer
NCT04131413HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
NCT05950139Prophylactic Cancer Peptide Vaccine in Advanced ALK+ NSCLC
NCT02017704Chemoradiation or Brachytherapy for Rectal Cancer
NCT05604560A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer